Trials / Terminated
TerminatedNCT01600443
Comparison of Microtrauma in Urethra After Usage of Different Catheters
A Randomized Cross-over Study on Urethral Microtrauma After Intermittent Catheterization.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Wellspect HealthCare · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study is undertaken to investigate if the urethral microtrauma, caused by intermittent catheterization, differs between three hydrophilic catheters for intermittent catheterization, LoFric; SpeediCath (SC) and SpeediCath Compact Male (SCCM). The study is a prospective, randomised, cross-over, single-centre study. Each subject will be randomized to use three different catheter types. Three catheterizations will be performed with each catheter type during one day, with at least two hours between each catheterization. The washout period between catheter switch will be at least one week. The primary objective is to evaluate urethral microtrauma for three hydrophilic catheters with regards to hematuria after intermittent catheterization. The secondary objectives are to evaluate urethral microtrauma for three hydrophilic catheters with regards to pyuria and subjective evaluation after intermittent catheterization. The safety of the three catheters will be evaluated in terms of adverse advents, non-serious and serious, rated for causality. The hypothesis that level of hematuria is equal after using different catheters will be tested using Wilcoxon signed rank test. The hypothesis will be rejected if the p-value is less than 5%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LoFric | Three catheterizations at least two hours apart using LoFric Primo 40 cm CH14. |
| DEVICE | SpeediCath | Three catheterizations at least two hours apart using SpeediCath 40 cm CH14. |
| DEVICE | SpeediCath Compact Male | Three catheterizations at least two hours apart using SpeediCath Compact Male 30 cm. |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2012-05-17
- Last updated
- 2014-02-03
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01600443. Inclusion in this directory is not an endorsement.